Skip to main content
. 2011 Aug 24;6(8):e23563. doi: 10.1371/journal.pone.0023563

Figure 3. Identification of candidate biomarkers with ELISA.

Figure 3

A) Nasal fluids from 40 patients with SAR before and after GC treatment were analyzed. B) Nasal fluids from 10 HR. Pre, patients before treatment with GCs; Post, patients after treatment with GCs.